Yuning Song and colleagues previously reported a CDC25 inhibitor, CHEQ-2, that not only inhibited the catalytic dephosphorylation activity of CDC25A and CDC25B in vitro, but also down-regulated CDC25A and CDC25B levels in cancer cells (29). Here, CDC25B is linked to cancer.